Viewing Study NCT02988518


Ignite Creation Date: 2025-12-25 @ 4:51 AM
Ignite Modification Date: 2026-03-05 @ 6:12 AM
Study NCT ID: NCT02988518
Status: UNKNOWN
Last Update Posted: 2016-12-09
First Post: 2016-08-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Cognitive Remediation on Patients With Bipolar Disorder and Memory Complaints
Sponsor:
Organization:

Raw JSON

{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D001714', 'term': 'Bipolar Disorder'}], 'ancestors': [{'id': 'D000068105', 'term': 'Bipolar and Related Disorders'}, {'id': 'D019964', 'term': 'Mood Disorders'}, {'id': 'D001523', 'term': 'Mental Disorders'}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'NA', 'maskingInfo': {'masking': 'NONE'}, 'primaryPurpose': 'SUPPORTIVE_CARE', 'interventionModel': 'SINGLE_GROUP'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 41}}, 'statusModule': {'overallStatus': 'UNKNOWN', 'lastKnownStatus': 'RECRUITING', 'startDateStruct': {'date': '2014-07'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2016-07', 'completionDateStruct': {'date': '2017-11', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2016-12-06', 'studyFirstSubmitDate': '2016-08-01', 'studyFirstSubmitQcDate': '2016-12-06', 'lastUpdatePostDateStruct': {'date': '2016-12-09', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2016-12-09', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2017-11', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Evolution of the global functioning between the inclusion and the end of the program', 'timeFrame': 'At 4 weeks', 'description': 'evaluation of variation of global functioning will be realized by the Functioning Assessment Short Test (FAST) scale after COGMED program.'}, {'measure': 'Evolution of the global functioning between the inclusion and the end of the program', 'timeFrame': 'At 6 weeks', 'description': 'evaluation of variation of global functioning will be realized by the Functioning Assessment Short Test (FAST) scale after COGMED program'}], 'secondaryOutcomes': [{'measure': 'Observance', 'timeFrame': 'At the inclusion and 4 to 6 weeks until the end of the program COGMED (11 to 13 weeks after inclusion)', 'description': "Evaluation of variation of patient's compliance by Medication Adherence Rating Scale (MARS) score after COGMED program."}, {'measure': 'Quality of life', 'timeFrame': 'At the inclusion and 4 to 6 weeks until the end of the program COGMED (11 to 13 weeks after inclusion)', 'description': 'Evaluation of variation of quality of life by Short Form (36) Health Survey (SF-36) score after COGMED program.'}, {'measure': 'Correlation between working memory and global functioning', 'timeFrame': 'At the inclusion and 4 to 6 weeks until the end of the program COGMED (11 to 13 weeks after inclusion)', 'description': 'Searching a statistical correlation between global functioning (using FAST) and working memory (using neuropsychological tests)'}, {'measure': 'Memory complaints', 'timeFrame': 'At the inclusion and 4 to 6 weeks until the end of the program COGMED (11 to 13 weeks after inclusion)', 'description': 'Variations on memory complaints will be evaluated by Mac Nair Scale score before and after COGMED program.'}]}, 'oversightModule': {'oversightHasDmc': False}, 'conditionsModule': {'keywords': ['Psychiatry', 'Bipolar disorder', 'Memory complaints', 'Global functioning', 'Cognitive remediation', 'Working memory'], 'conditions': ['Patient With Bipolar Disorder', 'Euthymic Status', 'Wirh Memory Complaints']}, 'descriptionModule': {'briefSummary': 'Bipolar disorder is a major health concern. Intercritical periods are marked with residual symptoms, both thymic and cognitive, which affects quality of life of patients, but also the quality of observance. The implementation of cognitive remediation programs could be interesting. The aim of this study is to evaluate the overall performance on euthymic bipolar patients with memory complaints included in the program named "COGMED", targeting the working memory.\n\nThe impact of this program on compliance, quality of life, and memory complaints will be evaluated.\n\nThe investigator will measure whether there is a correlation between working memory and overall performances.\n\nFinally, the investigator will try to achieve a profile of bipolar patients in whom the Cogmed program is particularly effective on a plan of overall performance.', 'detailedDescription': 'Patients with bipolar disorder and memory complaints will be recruited.\n\nTwo visits :\n\n1. at baseline (V0) : the investigator evaluate bipolar disorder, treatment, mood, quality of life, global functioning, and memory complaints. Patients also have a neuropsychological assessment. The COGMED program is proposed to patients with memory complaints and explain by the investigator\n2. 4-6 weeks after the end of the program (11-13 weeks after V1) : the same evaluation is realized to compare score before and after the program of cognitive remediation.\n\nBetween the two visits the patient will benefit of COGMED program, at home, during 5 weeks.\n\nCOGMED is a remediation cognitive program, based on working memory, consisting on daily exercises at home on a computer.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['CHILD', 'ADULT', 'OLDER_ADULT'], 'maximumAge': '65 Years', 'minimumAge': '18 Months', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion criteria:\n\n* Being diagnosed bipolar according to the Diagnostic and Statistical Manual of Mental Disorders - IV (DSM-IV) criteria\n* Memory complaints or overall performance alterations according to the memory scale (MEM III Wechsler memory scale - third edition)\n* Being euthymic at the inclusion according to Montgomery-Asberg Depression Rating Scale (MADRS \\< 12) and Young Mania Rating Scale (YMRS \\< 6)\n* Not being treated with electroconvulsive therapy for the last year\n* Not having drug-dependance or drug-abuse for the last six months\n* Having a computer with internet and a cellphone at home\n* Having signed informed consent\n* Able to understand nature, aims and methodology of the study\n\nExclusion criteria:\n\n* Patient on protective measures (guardianship or trusteeship)\n* Deprived of liberty subject (judicial or administrative decision)'}, 'identificationModule': {'nctId': 'NCT02988518', 'acronym': 'COGMED', 'briefTitle': 'Cognitive Remediation on Patients With Bipolar Disorder and Memory Complaints', 'organization': {'class': 'OTHER', 'fullName': 'University Hospital, Montpellier'}, 'officialTitle': 'Evaluation of a Cognitive Remediation Program on Patients With Bipolar Disorders, With Memory Complaints', 'orgStudyIdInfo': {'id': 'UF 9418'}, 'secondaryIdInfos': [{'id': '2014-A00825-42', 'type': 'OTHER', 'domain': 'Agence nationale de Sécurité des Médicaments'}]}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'COGMED program', 'description': 'Cognitive remediation using COGMED program on bipolar euthymic patients with memory complaints', 'interventionNames': ['Behavioral: COGMED program']}], 'interventions': [{'name': 'COGMED program', 'type': 'BEHAVIORAL', 'description': "Patient should connect on his computer at home, 5 times a week, for 5 weeks. Every day, the patient has to do 8 exercises for a total duration of 30 to 45 minutes.\n\nIn total, the patient will have to complete 25 sessions. The difficulty level of the proposed items adjust automatically to the patient's maximum capacity to compel him to provide a cognitive effort. A progression index assesses the progress made by the patient.\n\nEvery week, the investigator will call the patient for 10 minutes in order to gather the patient's feelings, his difficulties, provide some advice and encourage him.\n\nThe investigator will have to analyze the results of curves available for each event, as well as the patient's progress index.", 'armGroupLabels': ['COGMED program']}]}, 'contactsLocationsModule': {'locations': [{'zip': '34295', 'city': 'Montpellier', 'status': 'RECRUITING', 'country': 'France', 'contacts': [{'name': 'Catherine GENTY, MD', 'role': 'CONTACT', 'email': 'c-genty@chu-montpellier.fr', 'phone': '+33 4 67 99 61 45 75'}], 'facility': 'Montpellier University Hospital', 'geoPoint': {'lat': 43.61093, 'lon': 3.87635}}], 'centralContacts': [{'name': 'Emilie OLIE, MD PhD', 'role': 'CONTACT', 'email': 'e-olie@chu-montpellier.fr', 'phone': '+33 4 67 33 85 81'}]}, 'ipdSharingStatementModule': {'ipdSharing': 'NO'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'University Hospital, Montpellier', 'class': 'OTHER'}, 'responsibleParty': {'type': 'SPONSOR'}}}}